CORT: Summary for Corcept Therapeutics Incorporat - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 2:52am EST - Canadian Markets open in 6 hours and 38 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Corcept Therapeutics Inc. (CORT)

On Feb 9: 2.64 USD

0.06 (2.29%)

MORE ON CORT

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Corcept Therapeutics Incorporat (NCM:CORT) Delayed quote data

After Hours: 2.73

0.09 (3.41%) as of 4:00pm EST on 02/09/10

Last Trade:	2.64 USD
Trade Time:	Feb 9
Change:	0.06 (2.29%)
Prev Close:	2.58
Open:	2.61
Bid:	1.91 x 1000
Ask:	2.98 x 200
1y Target Est:	N/A

Day's Range:	2.57 - 2.64
52wk Range:	0.73 - 3.22
Volume:	15,098
Avg Vol (3m):	31,858.7
Market Cap:	164.93M
P/E (ttm):	N/A
EPS (ttm):	-0.37
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Add CORT to Portfolio

Download Data

HEADLINES

•	CORCEPT THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers
	EDGAR Online (Fri, Jan 8)

•	CORCEPT THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibit
	EDGAR Online (Thu, Jan 7)

•	Corcept Therapeutics upgraded by Ladenburg Thalmann
	Briefing.com (Wed, Jan 6)

•	Corcept Therapeutics Announces Four Anticipated Milestones for 2010
	Marketwire (Tue, Jan 5)

•	CORCEPT THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure,
	EDGAR Online (Thu, Nov 12)

•	Corcept Therapeutics Announces Recent Highlights and Third Quarter 2009 Financial Results
	Marketwire (Tue, Nov 10)

•	CORCEPT THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity
	EDGAR Online (Wed, Oct 14)

•	Corcept Therapeutics: Pump Up the Volume
	at TheStreet.com (Tue, Oct 13)

•	Corcept Therapeutics Announces Pricing of Private Placement Cash Sufficient to Fund Company Through Corlux NDA Submission
	Marketwire (Tue, Oct 13)

•	CORCEPT THERAPEUTICS INC Financials
	EDGAR Online Financials (Sat, Aug 22)

More Headlines for CORT...

ANALYST

EPS Est (next year) (Dec-07) :	N/A
EPS Est (in 2 years) (Dec-08) :	N/A
Avg Rec (current)*:	2.5
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Corcept Therapeutics Incorporated develops drugs for the treatment of severe psychiatric and metabolic diseases. The company, using its GR-II Antagonist Platform, primarily focuses on the development of drugs for disorders that are associated with...

Full Company Profile

Add to Portfolio

Email to a Friend

•